Found 4 matching trials
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma EARLY_PHASE1 This early phase I trial studies the biological activity of OMO-103 in pati...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC PHASE1 This study is an open-label, multicentre, Phase 1b trial designed to determ...
Show More Status
Active Not Recruiting
Location
Hospital Vall d´Hebrón
Learn More & Join Trial
A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma PHASE2 This is an open-label, unicentric, single-arm Phase 2 pilot study to serve ...
Show More Location
Hospital Universitari Vall d'Hebron
Learn More & Join Trial
Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours PHASE1 This study is an open label, two-part, First in Human (FIH) Phase 1/2 dose-...
Show More Location
University Hospital Vall d´Hebron
Learn More & Join Trial